MEDIFAST INC (MED) Financial Statements — Income, Balance Sheet, Cash Flow

Overview Financials Chart Business Summary Filings Ownership Valuation

Financial Statements — MED

Balance Sheet

(in millions USD)

Metric	Q2 2026	Q1 2026	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022	Q3 2021	Q2 2021	Q1 2021
Cash & Equivalents	71.91	71.53	99.53	101.69	91.72	115.31	108.02	97.47	112.75	147.41	123.75	69.71	61.07	118.00	154.52	191.99	206.03
Short-term Investments	97.91	97.42	73.99	60.98	72.88	54.65	55.49	58.96	--	--	--	0.00	0.00	4.06	5.38	5.44	6.88
Accounts Receivable	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	0.09
Inventory	21.18	21.40	23.21	30.20	39.36	40.10	39.60	46.27	58.23	68.90	96.90	145.28	156.97	188.97	129.61	95.79	62.23
Total Current Assets	202.03	202.63	207.84	206.44	213.52	224.98	224.32	219.58	224.28	228.82	230.32	229.58	243.30	324.26	301.05	304.32	281.86
Property, Plant & Equipment	27.98	29.64	32.85	34.60	36.31	39.00	39.92	50.99	53.48	54.41	55.96	58.11	58.54	57.80	46.45	37.38	31.11
Total Non-current Assets*	58.37	49.42	60.37	62.89	66.49	66.26	69.22	83.18	95.74	89.91	91.29	96.77	97.25	97.18	70.32	59.91	44.53
Total Assets	260.40	252.05	268.21	269.33	280.01	291.24	293.53	302.76	320.02	318.73	321.61	326.35	340.55	421.44	371.37	364.23	326.40
Accounts Payable	36.41	38.26	41.24	40.26	51.82	66.27	69.15	71.23	103.22	105.19	113.30	148.13	154.78	174.37	155.51	149.02	141.25
Total Current Liabilities	41.56	42.18	46.71	46.18	60.60	72.38	75.18	77.19	110.11	114.90	131.74	154.26	188.16	181.03	160.91	153.98	144.90
Total Non-current Liabilities*	22.46	12.18	6.79	7.14	8.45	11.52	13.07	14.61	16.87	18.27	18.96	21.57	22.91	24.38	14.22	15.57	6.60
Total Liabilities	64.02	54.37	53.50	53.33	69.05	83.90	88.25	91.80	126.98	133.16	150.71	175.83	211.07	205.41	175.13	169.55	151.50
Retained Earnings	153.05	156.15	176.24	178.49	176.01	175.98	174.85	182.97	168.78	163.89	151.83	131.50	129.20	203.05	183.16	185.34	178.56
Total Stockholder Equity	196.38	197.68	214.71	216.01	210.96	207.34	205.28	210.96	193.04	185.56	170.90	150.52	129.48	216.02	196.24	194.69	174.89

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Total Revenue	76.38	76.04	75.10	89.41	105.56	115.73	119.00	140.16	168.56	174.74	191.01	235.87	296.19	348.98	337.25	390.40	453.33	417.60	377.83	413.40
Cost of Revenue	22.99	24.29	22.96	27.25	28.91	31.48	30.78	34.49	45.12	47.45	49.65	58.49	85.47	102.59	103.65	107.55	131.65	115.31	99.55	106.34
Gross Profit	53.40	51.76	52.14	62.16	76.64	84.25	88.22	105.67	123.44	127.29	141.37	177.38	210.72	246.39	233.60	282.85	321.68	302.29	278.29	307.06
Selling, General & Admin	57.72	55.05	59.94	66.24	77.71	85.51	87.51	103.57	131.31	119.35	132.69	151.87	172.01	192.88	201.00	234.69	272.72	247.20	231.45	251.89
Total Operating Expenses	57.72	55.05	59.94	66.24	77.71	85.51	87.51	103.57	131.31	119.35	132.69	151.87	172.01	192.88	201.00	234.69	272.72	247.20	231.45	251.89
Operating Income	(4.33)	(3.29)	(7.80)	(4.08)	(1.07)	(1.26)	0.71	2.11	(7.88)	7.94	8.68	25.51	38.71	53.51	32.60	48.16	48.96	55.09	46.84	55.17
Pretax Income	(2.99)	(1.94)	(6.38)	(2.66)	2.88	0.53	1.27	1.58	(10.65)	11.59	9.80	26.55	39.12	53.33	32.41	47.88	48.80	54.98	46.75	55.19
Tax Provision	0.11	0.18	11.74	(0.40)	0.40	1.30	0.47	0.45	(2.50)	3.27	3.77	3.42	8.84	13.36	5.89	11.72	9.68	13.20	12.73	13.21
Net Income	(3.10)	(2.12)	(18.12)	(2.26)	2.48	(0.77)	0.80	1.13	(8.15)	8.32	6.04	23.13	30.28	39.97	26.52	36.16	39.11	41.78	34.02	41.98
Basic EPS	(0.28)	(0.19)	(1.65)	(0.21)	0.23	(0.07)	0.08	0.10	(0.75)	0.76	0.55	2.12	2.78	3.68	2.46	3.30	3.44	3.62	2.93	3.59
Diluted EPS	(0.28)	(0.19)	(1.64)	(0.21)	0.22	(0.07)	0.08	0.10	(0.75)	0.76	0.54	2.12	2.77	3.67	2.45	3.27	3.42	3.59	2.91	3.56

Cash Flow Statement

(in millions USD)

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Operating Cash Flow	1.70	0.26	(5.28)	12.11	(3.38)	3.41	(4.95)	9.07	13.07	7.28	10.52	29.93	43.15	64.06	51.74	55.40	43.76	43.67	(7.46)	15.80
Capital Expenditures	0.97	1.10	1.35	1.36	1.38	1.52	2.29	1.39	1.94	1.84	0.95	1.68	1.74	2.12	9.06	1.77	2.84	3.01	11.62	10.39
Free Cash Flow*	0.73	(0.84)	(6.63)	10.75	(4.76)	1.88	(7.23)	7.68	11.13	5.44	9.58	28.25	41.40	61.94	42.68	53.63	40.92	40.66	(19.08)	5.41
Investing Cash Flow	(1.23)	(17.13)	(4.95)	(14.28)	13.36	(2.05)	(19.43)	(1.78)	(2.53)	(2.77)	(10.73)	(46.46)	(1.74)	(2.12)	(9.06)	(1.77)	1.18	(1.76)	(11.62)	(10.39)
Financing Cash Flow	(0.08)	(0.90)	0.00	0.00	-0.00	(0.56)	-0.00	-0.00	(0.02)	(1.49)	(17.90)	(18.15)	(17.83)	(25.90)	(24.33)	(45.11)	(102.02)	(28.12)	(31.23)	(42.94)

* Derived from reported values

Dividends Per Share

(USD)

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020
Dividends Per Share	0.00	0.00	0.00	0.00	0.00	1.65	1.65	1.65	1.64	1.64	1.64	1.64	1.42	1.42	1.42	1.42	1.13	1.13	1.13	1.13